Jubilant Ingrevia Limited has launched a new cGMP-compliant manufacturing facility in Bharuch, Gujarat, aimed at producing nutraceuticals and dietary ingredients. This facility will help the company expand its reach in food, nutrition, cosmetics and infant nutrition markets worldwide.
Jubilant Ingrevia Limited has opened a new facility in Bharuch, Gujarat, to produce nutraceuticals and dietary ingredients for people. This facility is an addition to their USFDA-approved plant, which already supplies to the U.S., Europe, Japan and other regions. With a capacity of 5,000 metric tonnes, the new plant will make high-quality products for top global brands in food, nutrition and cosmetics. It also plans to supply food-grade Niacin for the infant nutrition market.
The new facility will help Jubilant Ingrevia become a stronger global leader in producing Niacinamide (Vitamin B3). It will focus on making high-quality products with high bio-content, targeting profitable markets like skincare, hair care and infant nutrition. This gives the company a competitive edge by reducing dependence on lower-margin products and supporting customers who prefer sustainable and eco-friendly options.
The facility is part of Jubilant Ingrevia’s eco-friendly and fully integrated supply chain in the Nutrition & Health Ingredients business. Its sustainable production methods attract global brands looking for high-quality, environmentally friendly products. The company is already in talks with major international clients about starting to supply these products.
Jubilant Ingrevia Limited is a global leader in Life Sciences and Specialty Chemicals with over 40 years of experience. They manufacture a wide range of products, including Vitamin B3, etc. and serve industries like pharmaceuticals, agrochemicals and consumer goods. The company operates 50 plants across India, employs over 2,300 people, and has been recognised for innovation, sustainability and 4IR technologies.
As of January 27, 2025, at 12:00 PM, With a market capitalisation of ₹107.11 billion, Jubilant Ingrevia’s shares are trading at ₹676.95 per share, down 1.87% from the previous closing price. Over the last month, the stock has fallen by 15.47% and over the past year, it has declined by 17.79%. The stock has a 52-week high and 52-week low of ₹885 per share and ₹420 per share, respectively.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jan 27, 2025, 3:27 PM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
